Viewing Study NCT05939128


Ignite Creation Date: 2025-12-26 @ 10:36 AM
Ignite Modification Date: 2026-01-01 @ 1:42 AM
Study NCT ID: NCT05939128
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-23
First Post: 2023-07-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Non-interventional Prospective Study of Early HER2-negative High-risk Breast Cancer and BRCA1/2 Mutations Prevalence in RussiA
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module